Stories

2021 Updates: Lilly's Global COVID-19 Response

View Story

2020 Updates: Lilly's Global COVID-19 Response

View Story

Digital Health: Partnering to Improve Outcomes

View Story

Naming a New Drug During a Pandemic

View Story

Lilly's COVID-19 Science Leads to a Second FDA Emergency Use Authorization

View Story

When the World Called for Help with COVID-19, We Were Ready

View Story

Dave Ricks Shares About Lilly's FDA Emergency Use Authorization for a Neutralizing Antibody

View Story

CEO Dave Ricks Shares Lilly's Principles of COVID-19 Antibody Therapy Pricing and Access

View Story

What Does It Take to Manufacture Neutralizing Antibodies?

View Story

The Power of Loxo Oncology at Lilly

View Story